Additionally, analysis using online software—DiseaseMeth 2.0 [27] revealed that MAGI2-AS3 promoter was hypermethylated in several cancers such as colon adenocarcinoma, head and neck carcinoma, uterine endometrial carcinoma, and rectal and anal adenocarcinoma. This evidence concerns the gene MAGI2 and anus adenocarcinoma.